HeimLLY • FRA
add
Eli Lilly And Co
Við síðustu lokun
868,10 €
Dagbil
825,00 € - 859,80 €
Árabil
395,20 € - 885,00 €
Markaðsvirði
867,67 ma. USD
Meðalmagn
642,00
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | mar. 2024info | Breyting á/á |
---|---|---|
Tekjur | 8,77 ma. | 25,98% |
Rekstrarkostnaður | 4,36 ma. | 20,46% |
Nettótekjur | 2,24 ma. | 66,77% |
Hagnaðarhlutfall | 25,58 | 32,40% |
Hagnaður á hvern hlut | 2,58 | 59,26% |
EBITDA | 3,14 ma. | 50,99% |
Virkt skatthlutfall | 11,56% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | mar. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 2,65 ma. | -28,79% |
Heildareignir | 63,94 ma. | 20,28% |
Heildarskuldir | 51,05 ma. | 21,92% |
Eigið fé alls | 12,90 ma. | — |
Útistandandi hlutabréf | 900,41 m. | — |
Eiginfjárgengi | 61,00 | — |
Arðsemi eigna | 10,69% | — |
Ávöxtun eigin fjár | 17,86% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | mar. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 2,24 ma. | 66,77% |
Handbært fé frá rekstri | 1,17 ma. | -32,62% |
Reiðufé frá fjárfestingum | -1,18 ma. | -70,96% |
Reiðufé frá fjármögnun | -311,30 m. | -175,50% |
Breyting á handbæru fé | -358,40 m. | -124,23% |
Frjálst peningaflæði | -2,01 ma. | -273,63% |
Um
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.
As of 2024, the company is ranked 127th on the Fortune 500 with revenue of $34.12 billion. It is ranked 221st on the Forbes Global 2000 list of the world's largest publicly-traded companies and 252nd on the Forbes list of "America's Best Employers". It is recognized as the top entry-level employer in Indianapolis.
Lilly is known for its clinical depression drugs Prozac, Cymbalta, and its antipsychotic medication Zyprexa. The company's primary revenue drivers are the diabetes drugs Humalog and Trulicity.
Lilly was the first company to mass-produce both the polio vaccine, developed in 1955 by Jonas Salk, and insulin. It was one of the first pharmaceutical companies to produce human insulin using recombinant DNA, including Humulin, Humalog, and the first approved biosimilar insulin product in the U.S., Basaglar. Wikipedia
Framkvæmdastjóri
Stofnsett
1876
Höfuðstöðvar
Vefsvæði
Starfsfólk
43.000